215 related articles for article (PubMed ID: 11711598)
1. Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription.
Khan M; Garcia-Barrio M; Powell MD
J Virol; 2001 Dec; 75(24):12081-7. PubMed ID: 11711598
[TBL] [Abstract][Full Text] [Related]
2. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.
Aiken C; Trono D
J Virol; 1995 Aug; 69(8):5048-56. PubMed ID: 7541845
[TBL] [Abstract][Full Text] [Related]
3. Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity.
Miller MD; Warmerdam MT; Ferrell SS; Benitez R; Greene WC
Virology; 1997 Aug; 234(2):215-25. PubMed ID: 9268152
[TBL] [Abstract][Full Text] [Related]
4. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein.
Pandori MW; Fitch NJ; Craig HM; Richman DD; Spina CA; Guatelli JC
J Virol; 1996 Jul; 70(7):4283-90. PubMed ID: 8676450
[TBL] [Abstract][Full Text] [Related]
5. Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope.
Zhou J; Aiken C
J Virol; 2001 Jul; 75(13):5851-9. PubMed ID: 11390586
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.
Schaeffer E; Geleziunas R; Greene WC
J Virol; 2001 Mar; 75(6):2993-3000. PubMed ID: 11222724
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity.
Chazal N; Singer G; Aiken C; Hammarskjöld ML; Rekosh D
J Virol; 2001 Apr; 75(8):4014-8. PubMed ID: 11264394
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell.
Schwartz O; Maréchal V; Danos O; Heard JM
J Virol; 1995 Jul; 69(7):4053-9. PubMed ID: 7539505
[TBL] [Abstract][Full Text] [Related]
9. Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity.
Campbell EM; Nunez R; Hope TJ
J Virol; 2004 Jun; 78(11):5745-55. PubMed ID: 15140972
[TBL] [Abstract][Full Text] [Related]
10. Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of vif for optimal infectivity: functional difference between Vif and Nef.
Akari H; Uchiyama T; Fukumori T; Iida S; Koyama AH; Adachi A
J Gen Virol; 1999 Nov; 80 ( Pt 11)():2945-2949. PubMed ID: 10580056
[TBL] [Abstract][Full Text] [Related]
11. Association of Nef with the human immunodeficiency virus type 1 core.
Kotov A; Zhou J; Flicker P; Aiken C
J Virol; 1999 Oct; 73(10):8824-30. PubMed ID: 10482638
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type I Nef independently affects virion incorporation of major histocompatibility complex class I molecules and virus infectivity.
Le Gall S; Prevost MC; Heard JM; Schwartz O
Virology; 1997 Mar; 229(1):295-301. PubMed ID: 9123874
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic independence of Nef and cyclophilin A enhancement of human immunodeficiency virus type 1 infectivity.
Aiken C
Virology; 1998 Aug; 248(1):139-47. PubMed ID: 9705263
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of human immunodeficiency virus type 1 infectivity by Nef is producer cell-dependent.
Tokunaga K; Kojima A; Kurata T; Ikuta K; Akari H; Koyama AH; Kawamura M; Inubushi R; Shimano R; Adachi A
J Gen Virol; 1998 Oct; 79 ( Pt 10)():2447-53. PubMed ID: 9780050
[TBL] [Abstract][Full Text] [Related]
15. Virological importance of the protease-cleavage site in human immunodeficiency virus type 1 Nef is independent of both intravirion processing and CD4 down-regulation.
Pandori M; Craig H; Moutouh L; Corbeil J; Guatelli J
Virology; 1998 Nov; 251(2):302-16. PubMed ID: 9837795
[TBL] [Abstract][Full Text] [Related]
16. The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation.
Chowers MY; Pandori MW; Spina CA; Richman DD; Guatelli JC
Virology; 1995 Oct; 212(2):451-7. PubMed ID: 7571414
[TBL] [Abstract][Full Text] [Related]
17. Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: evidence indicating that reverse transcription may not take place within the intact viral core.
Zhang H; Dornadula G; Orenstein J; Pomerantz RJ
J Hum Virol; 2000; 3(3):165-72. PubMed ID: 10881997
[TBL] [Abstract][Full Text] [Related]
18. Treatment of human immunodeficiency virus type 1 virions depleted of cyclophilin A by natural endogenous reverse transcription restores infectivity.
Khan M; Garcia-Barrio M; Powell MD
J Virol; 2003 Apr; 77(7):4431-4. PubMed ID: 12634401
[TBL] [Abstract][Full Text] [Related]
19. Cell-dependent functional roles of HIV-1 Nef for virus replication (review).
Adachi A; Oshima Y
Int J Mol Med; 1999 Apr; 3(4):427-30. PubMed ID: 10085418
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase.
Welker R; Kottler H; Kalbitzer HR; Kräusslich HG
Virology; 1996 May; 219(1):228-36. PubMed ID: 8623533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
